Literature DB >> 21145134

[High exposure to antibiotics in the population and differences by sex and age].

M Catalina Serna1, Esther Ribes, Jordi Real, Leonardo Galván, Eduardo Gascó, Pere Godoy.   

Abstract

PURPOSE: To determine antibiotic use and its distribution by age and gender, as well as the most prescribed therapeutic group.
DESIGN: Observational descriptive with retrospective data. SETTINGS AND PARTICIPANTS: Population from the Lleida (Spain) Health Region receiving antibiotic prescriptions from 2002 to 2007. MEASUREMENTS: Daily Dose Per Inhabitant (DID) was calculated, as well as the number of patients under treatment. The study variables were: age, gender, number of patients under antibiotic treatment and pharmacological group.
RESULTS: Mean prevalence of patients receiving antibiotics was 36.93% (33.51% in men and 40.42% in women). The DID in Lleida during 2007 is 23.52. The majority (56%) had received antibiotics once a year. The antibiotic consumption prevalence has a "V" shape with higher values among children and old people. There is an annual exposure to antibiotics in 58.8% of the 0 to 4 years-old age group. The most prescribed antibiotic is amoxicillin/clavulanic.
CONCLUSIONS: We observe a high antibiotic prescription rate among children and older people, the high consumption in childhood being of note. There is also a higher use of antibiotics among women and changing of prescription towards broad spectrum antibiotics.
Copyright © 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145134      PMCID: PMC7024977          DOI: 10.1016/j.aprim.2010.04.015

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  18 in total

Review 1.  Antibiotic use and population ecology: how you can reduce your "resistance footprint".

Authors:  David M Patrick; James Hutchinson
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

2.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Authors:  H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

3.  Cross-cultural differences in lay attitudes and utilisation of antibiotics in a Belgian and a Dutch city.

Authors:  Reginald Deschepper; Robert H Vander Stichele; Flora M Haaijer-Ruskamp
Journal:  Patient Educ Couns       Date:  2002 Oct -Nov

4.  Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet.

Authors:  John Macfarlane; William Holmes; Philip Gard; David Thornhill; Rosamund Macfarlane; Richard Hubbard
Journal:  BMJ       Date:  2002-01-12

5.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

6.  Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain.

Authors:  Lars Bjerrum; Albert Boada; Josep M Cots; Carlos Llor; Dolors Forés Garcia; Bente Gahrn-Hansen; Anders Munck
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

7.  Antibiotic utilisation in community practices: guideline concurrence and prescription necessity.

Authors:  Susan Jelinski; Patrick Parfrey; James Hutchinson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-05       Impact factor: 2.890

8.  A European study on the relationship between antimicrobial use and antimicrobial resistance.

Authors:  Stef L A M Bronzwaer; Otto Cars; Udo Buchholz; Sigvard Mölstad; Wim Goettsch; Irene K Veldhuijzen; Jacob L Kool; Marc J W Sprenger; John E Degener
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

9.  European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe.

Authors:  Samuel Coenen; Matus Ferech; Flora M Haaijer-Ruskamp; Chris C Butler; Robert H Vander Stichele; Theo J M Verheij; Dominique L Monnet; Paul Little; Herman Goossens
Journal:  Qual Saf Health Care       Date:  2007-12

10.  Antimicrobial drug use and resistance in Europe.

Authors:  Nienke van de Sande-Bruinsma; Hajo Grundmann; Didier Verloo; Edine Tiemersma; Jos Monen; Herman Goossens; Matus Ferech
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

View more
  5 in total

1.  [Defined daily doses: a high antibioptic prescription rate?].

Authors:  Juan Simó Miñana
Journal:  Aten Primaria       Date:  2011-10-19       Impact factor: 1.137

2.  Improving the appropriateness of antimicrobial use in primary care after implementation of a local antimicrobial guide in both levels of care.

Authors:  Rocío Fernández Urrusuno; Macarena Flores Dorado; Angel Vilches Arenas; Carmen Serrano Martino; Susana Corral Baena; Ma Carmen Montero Balosa
Journal:  Eur J Clin Pharmacol       Date:  2014-06-03       Impact factor: 2.953

3.  The quality of outpatient antimicrobial prescribing: a comparison between two areas of northern and southern Europe.

Authors:  Sara Malo; Lars Bjerrum; Cristina Feja; María Jesús Lallana; José María Abad; María José Rabanaque-Hernández
Journal:  Eur J Clin Pharmacol       Date:  2013-12-10       Impact factor: 2.953

4.  Prescribing Patterns for Acute Respiratory Infections in Children in Primary Health Care Centers, Makkah Al Mukarramah, Saudi Arabia.

Authors:  M H Shaheen; M I Siddiqui; H A Jokhdar; A Hassan-Hussein; M A Garout; S M Hafiz; M M Alshareef; A M Falemban; A A Neveen; A A Nermeen
Journal:  J Epidemiol Glob Health       Date:  2018-12

5.  [Variability between health areas in antibiotic consumption among pediatric outpatients of Principado de Asturias, Spain (2005-2018)].

Authors:  L Calle-Miguel; G Modroño Riaño; A I Iglesias Carbajo; M A Alonso Álvarez; C Vicente Martínez; G Solís Sánchez
Journal:  Rev Esp Quimioter       Date:  2021-01-26       Impact factor: 1.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.